Budesonide and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Budesonide (budesonide), especially for people who are male, 60+ old, also take Prednisone, and have Epilepsy.

The phase IV clinical study analyzes which people have Status epilepticus when taking Budesonide. It is created by eHealthMe based on reports of 42,490 people who have side effects when taking Budesonide from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 664 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

42,490 people reported to have side effects when taking Budesonide.
Among them, 27 people (0.06%) have Status epilepticus.

Could Budesonide cause Status epilepticus?

Among these 27 people:

What is the gender of people who have Status epilepticus when taking Budesonide? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Status epilepticus when taking Budesonide? *

What are other drugs people take besides Budesonide? *

What are other side effects people have besides Status epilepticus? *

Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions): 10 people, 37.04%
Fever: 10 people, 37.04%
Hypoacusis (loss of hearing): 8 people, 29.63%
Coma Scale Abnormal: 6 people, 22.22%
Infarction (obstruction of the blood supply to an organ or region of tissue): 6 people, 22.22%
Colitis (inflammation of colon): 5 people, 18.52%
Growth Retardation (delayed growth): 4 people, 14.81%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 4 people, 14.81%
Staphylococcal Abscess (pus formation due to staphylococcal bacteria): 4 people, 14.81%
Osteoporosis (bones weak and more likely to break): 4 people, 14.81%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 14.81%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 11.11%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 3.70%
Quit Smoking: 1 person, 3.70%
Psychotic Disorder: 1 person, 3.70%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 3.70%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 3.70%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 3.70%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.70%
High Blood Pressure: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Budesonide:

Budesonide (42,933 reports)

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Status epilepticus (664 drugs)

Browse all the conditions that are associated with Status epilepticus:

Status epilepticus (949 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Budesonide) and Budesonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.